Research in the School of Dentistry

Research at the School of Dentistry

Ranked first in the country for Dentistry in terms of 4* and 3* research, academics have joined forces with leading global industry names such as Unilever, Philips and Mars to trial new products which will have health impacts far beyond dental issues, including in diabetes and heart disease. The research has also led to a number of disease assessment tools being launched for high- street dentists, and low-cost tests to help people to stop smoking. In 2015, following significant investment, the first new dental hospital in the UK for 40 years will open as the new home for the University’s School of Dentistry.

UPDATE – AUGUST 2015 - Due to a number of challenges with the construction programme, a decision has been taken by all partners to reschedule the opening of the new Birmingham Dental Hospital and School of Dentistry.  This has been agreed in order to minimise disruption and maintain continuity of service for patients, students and staff. All partners will be working closely together over the coming weeks to revise the programme of works with a new opening date. Once agreed this will be communicated, it is expected that the new opening date will be known by Welcome week.

Oral infectious and inflammatory diseases are the most common human diseases worldwide and cause significant morbidity, impacting upon general health, wellbeing and mortality rates. Their impact on the economy is substantial. Our research is making significant inroads into understanding their pathobiology and translating this into novel treatments.

Oral cancer is currently the 6th most common form of cancer with survival rates of only 60% and we aim to impact significantly upon these statistics through our collaborative research activities. Our interdisciplinary research excellence in the field of tissue repair, regeneration and rehabilitation draws upon multi-disciplinary expertise in the biological, physical and biological sciences to improve current, and develop future, therapeutic solutions.

Our clinician-basic science partnerships provide broad expertise and enable us to exploit our findings through clinical trials of novel diagnostics and therapeutics in collaboration with our NHS partners. While our state-of-the-art purpose built laboratories and associated clinics house cutting-edge technologies enabling us to explore disease mechanisms, improve our understanding of pathogenic processes, and formulate new healthcare solutions.

The strengths of our internationally-leading teams centre on developing a sound understanding of disease mechanisms to underpin novel diagnostic, tissue regenerative and engineering therapeutic strategies for periodontal diseases, caries and oral cancer; and are enhanced by strong local, national and international (Europe, North/South America, Far-East, Asia) collaborations.

Our focus on the scientific basis of oral and dental disease is providing innovative solutions to important problems significantly impacting the population and is helping us to deliver our vision for improving oral and general health.